Importance of using current NCCLS breakpoints to interpret cefotaxime and ceftriaxone MICs for Streptococcus pneumoniae.
Karlowsky
James A
JA
Jones
Mark E
ME
D002439:Cefotaxime / Q000494:pharmacology*; D002443:Ceftriaxone / Q000494:pharmacology*; D002511:Cephalosporins / Q000494:pharmacology*; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000592:standards; D011008:Pneumococcal Infections / Q000134:cerebrospinal fluid / Q000382:microbiology; D012015:Reference Standards; D013296:Streptococcus pneumoniae / Q000187:drug effects*
D002511:Cephalosporins; D002443:Ceftriaxone; D002439:Cefotaxime